...
首页> 外文期刊>Seminars in musculoskeletal radiology >New perspectives on bone marrow contrast agents and molecular imaging.
【24h】

New perspectives on bone marrow contrast agents and molecular imaging.

机译:骨髓造影剂和分子成像的新观点。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Magnetic resonance (MR) imaging of bone marrow provides a noninvasive diagnosis of the vascularity, cell quantity, and composition of the normal and pathological bone marrow. This article reviews new and evolving techniques for bone marrow MR imaging with a special focus on translational and clinical applications. Evaluations of bone marrow perfusion with standard small molecular contrast agents and, more recently, with macromolecular contrast agents are currently being applied for therapy monitoring. Cell-specific contrast agents are expected to improve the sensitivity and specificity of bone marrow MR imaging. Novel cellular and molecular imaging techniques for the depiction of cell metabolism and specific biochemical pathways are discussed. Cell tracking techniques may allow specific diagnoses of inflammatory processes as well as monitoring of novel therapies based on stem cells. Future developments of fusion imaging techniques and bifunctional contrast agents are directed to combine comprehensive information about bone marrow structure and function with targeted and image-guided therapies.
机译:骨髓的磁共振(MR)成像可对正常和病理性骨髓的血管,细胞数量和成分进行无创诊断。本文介绍了针对骨髓MR成像的新兴技术,其中特别关注转化和临床应用。目前,将标准的小分子造影剂以及最近的大分子造影剂用于骨髓灌注的评估用于治疗监测。预期细胞特异性造影剂将改善骨髓MR成像的敏感性和特异性。讨论了用于细胞代谢和特定生化途径描述的新型细胞和分子成像技术。细胞跟踪技术可允许对炎症过程进行特定诊断,并基于干细胞监测新疗法。融合成像技术和双功能造影剂的未来发展旨在将有关骨髓结构和功能的全面信息与靶向和图像引导疗法相结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号